Publications by authors named "Y Balabanova"

Claim this Profile
C
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study.
Marie Linder, Anders Ekbom, Gunnar Brobert, Kai Vogtländer, Yanina Balabanova

J Thromb Thrombolysis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Yanina Balabanova

PLoS One· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
Gunnar Brobert, Ana Ruigomez, Tania Schink, Annemarie Voss, Ron Herings, Yanina Balabanova

BMJ Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.
Luis Alberto García Rodríguez, Ana Ruigómez, Tania Schink, Annemarie Voss, Elisabeth Smits, Yanina Balabanova

Expert Opin Drug Saf· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults.
Natalie Ebert, Alice Schneider, Doerte Huscher, Nina Mielke, Yanina Balabanova

BMC Nephrol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis